Navigation Links
Guidelines for treatment of juvenile idiopathic arthritis formulated

Juvenile rheumatoid arthritis affects approximately one in every 1,000 children and is characterized by the inflammation of joints. Several genetic and environmental factors have been as causative factors for the disorder. // The onset of the condition typically occurs before the age of 16. There is no satisfactory treatment available. However, targeted treatment has been shown to improve symptoms significantly.

The five most common types of JIA are oligoarthritis, which accounts for 50 per cent of cases and involves the swelling of less than five joints; polyarthritis, with swelling of more than five joints; systemic arthritis, characterized by high fevers and a rash with swelling of other organs in addition to joints; enthesitis-related arthritis, which may affect the spine and hips; and psoriatic arthritis, where children have psoriasis in addition to swollen joints. The incidence of the disease is more among Canadian children and if untreated, it can lead to significant developmental damage to the bones, joints and muscles. A study published by the Cleveland Clinic and The Hospital for Sick Children (SickKids) provides the medical community for the first time with specific guidelines for treating juvenile idiopathic arthritis (JIA), previously known as juvenile rheumatoid arthritis. To date, a clear approach for treating the different forms of the disease has not existed, despite many advances in the treatment of JIA.

The guidelines in the JAMA study summarize the current evidence-based medical practices for JIA and provide physicians with a rational approach for treating the various subtypes of the disease. By examining a patients' symptoms physicians can determine the type of arthritis they have and what approach is most appropriate for treating their condition.

The key to the effective management of the condition according to the researchers is providing the correct treatment depending on the symptoms of the patient. To
'"/>




Page: 1 2

Related medicine news :

1. New CPR Guidelines issued by Heart Association
2. New Guidelines Found To Benefit Cardiovascular Treatment
3. Healthy Feeding Guidelines for Children Ages 0 to 24 Months Issued
4. Fragile X-Associated Tremor /Ataxia Syndrome Need Guidelines For Diagnostic Tests
5. Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices
6. FDA To Set New Guidelines To Revise Drug Companies Marketing Tactics
7. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
8. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
9. Guidelines For Better Management Of Obsessive-Compulsive Disorder
10. Poultry Workers To Adopt Anti-Flu Guidelines
11. Guidelines to tackle bird flu pandemic

Post Your Comments:
(Date:11/25/2009)...FRANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQuality... Spare the Air Alert forThursday,Nov...ogsoranyothersolidfuel,bothindoorsandoutdoors. ,...ualitytomorrow,"saidJackBroadbent,executiveofficer...pectthehealthoftheirneighborsandfellowcommunitymem...
(Date:11/25/2009)... survivors of testicular cancer who were treated w...ide effects, including neurological side effects a...reated with chemotherapy, according to a new study...he National Cancer Institute . , Marianne Brydy,...iversity Hospital, in Bergen, Norway, and colleagu...
(Date:11/25/2009)...itous discovery that grew out of a collaboration b...ally offer hope to the nearly 10 million Americans..., Also known as hardening of the arteries, perip...atory problem in which narrowed arteries reduce bl... a red flag for vascular disease, heart attack and...
(Date:11/25/2009)...ollow-up period was too short to draw definite con...ov. 25 (HealthDay News) -- In diabetic patients wi...no difference in outcomes at one year whether pati...enting, British researchers report. , Bypass su... patients with coronary artery disease. However, l...
(Date:11/25/2009)... Evaluation and treatment clinics to... Woodstock (Vocus) November 25, 2009 -- Centegra H...cines and H1N1 vaccine shots at four Centegra Prim...hipment of vaccine has arrived. The clinics are at... McHenry and will be open as follows: ,  ...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...1, 2009 AMERIGROUP Corporation (NYSE: AGP ) t...r the fourth quarter ended December 31, 2008, befo.... At 8:30 a.m. Eastern Time on the same day, AMER...domestic) or 706-679-7245 (international) approxim...
...n observance of National Children,s Dental Health ... Association (PDA) is sponsoring its annual poster...re eligible to participate in the contest. , , T...lic libraries. In addition to the student prize, t...
...ould detect virus that can lead to failure, , ... urine test that can detect a common cause of kidn...nosis and treatment of patients with polyomavirus ...ems for people with compromised immune systems. Pe...
...ticle pollution correlate with increases in life e...y News) -- A new study shows there is a direct rel...tants in the air people breathe and life expectanc... meter of air adds about seven months of life expe...
...thy infant feeding can help stem the staggering ri...tate University nursing professor who will use a $...r infant feeding program. , Mildred Horodynski of...ces, known as infant-centered feeding. , Her thre...
...Pharmaceuticals, Inc. (Nasdaq: AMLN ) will webca...urth quarter and full year 2008 on Tuesday, Januar... Bradbury, Amylin,s president and chief executive ...08. , , The call will be webcast live through A...
Other Medicine News:Health News:AMERIGROUP Corporation to Discuss Fourth Quarter Earnings on February 19 2Health News:New Test May Help Kidney Transplant Patients 2Health News:Cleaner Air Equals Longer Life 2Health News:Cleaner Air Equals Longer Life 3Health News:MSU researcher receives $1.5 million grant for childhood obesity intervention study 2Health News:Amylin Pharmaceuticals to Webcast Year-End Results 2
(Date:11/25/2009)...-NuVasive,Inc.(Nasdaq: NUVA ),amedicaldevicecompan...surgicaltreatmentsforthespine,announcedtodaythatit...5:30p.m.ET/2:30p.m.PT.Theconferencecallwillfocuson...sproductsandwillincludecommentsfrommanagementfollo...ersare1-877-407-4018fordomesticcallersand1-201-689...
(Date:11/25/2009)...er.comannouncesthatanewmarketresearchreportisavail...USMarketTrends&Analysis http://www.reportlink...et-Trends--Analysis.html ,, TheUSintranasaldru...capplicationsfromthedeliveryofconventionallocalthe...gs.Thefutureofthetechnologyhingesontotheeffectivee...
(Date:11/25/2009)...-- ChemoCentryx,Inc.,announcedtodaythatPhaseII/II...iveRandomizedOralTherapyEvaluationinCrohn,sdisease...erate-to-severeCrohn,sdiseasedemonstratedclinicale...Thestudydemonstratedevidenceofclinicalefficacyinth...reaseintheCrohn,sDiseaseActivityIndex(CDAI)inpatie...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Access Pharmaceuticals Provides Update on ProLindac 28TM 29 Phase 2 Ovarian Cancer Trial and Clinical Development Plan 47461 1Access Pharmaceuticals Provides Update on ProLindac 28TM 29 Phase 2 Ovarian Cancer Trial and Clinical Development Plan 47461 2Access Pharmaceuticals Provides Update on ProLindac 28TM 29 Phase 2 Ovarian Cancer Trial and Clinical Development Plan 47461 3Access Pharmaceuticals Provides Update on ProLindac 28TM 29 Phase 2 Ovarian Cancer Trial and Clinical Development Plan 47461 4BayCare Named CIO 100 Award Winner by CIO Magazine 47458 1BayCare Named CIO 100 Award Winner by CIO Magazine 47458 2BayCare Named CIO 100 Award Winner by CIO Magazine 47458 3National Museum of Dentistry Opens New Smile Experience Exhibition Recognizes Dr Irwin Smigel as Father of Aesthetic Dentistry 47455 1National Museum of Dentistry Opens New Smile Experience Exhibition Recognizes Dr Irwin Smigel as Father of Aesthetic Dentistry 47455 2National Museum of Dentistry Opens New Smile Experience Exhibition Recognizes Dr Irwin Smigel as Father of Aesthetic Dentistry 47455 3
...7 Trius Therapeutics, Inc. announced,today that i...-701, an,antibacterial drug candidate intended for...bacterial infections, including those caused by MR...ght subject single and,multiple ascending dose tri...tics of the oral dosage form of the drug and will ...
...uided Nanoparticles May Deliver Treatments to Huma... used,magnetic fields and tiny iron-bearing partic...ood vessels. The research, done in animals, may le...o repair injured or diseased,organs in people., (...07/DC10966 ), The study team, led by Robert J. L...
Other Medicine Technology:Trius Initiates U.S. Phase I Trial for its Oxazolidinone Antibacterial Drug, TR-701 2Researchers Use Magnetism to Target Cells to Animal Arteries 2Researchers Use Magnetism to Target Cells to Animal Arteries 3Researchers Use Magnetism to Target Cells to Animal Arteries 4
Fixed Core Straight Safety Wire Guides - Standard (PTFE coated)
Fixed Core Straight Safety Wire Guides - Standard (stainless steel)
Fascial Incising Needles
Two-Part Trocar Needles - Standard
Medicine Products: